<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A"><gtr:id>2512972D-6FE3-48FC-8B6B-CBD2BA6CE18A</gtr:id><gtr:name>Missouri University of Science and Tech</gtr:name><gtr:address><gtr:line1>Missouri University of Science and Tech</gtr:line1><gtr:line2>1870 Miner Circle</gtr:line2><gtr:line4>Rolla</gtr:line4><gtr:line5>Missouri</gtr:line5><gtr:postCode>MO 65409</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7FE748F9-B181-4A3F-A8D1-340B794E3774"><gtr:id>7FE748F9-B181-4A3F-A8D1-340B794E3774</gtr:id><gtr:firstName>Inge</gtr:firstName><gtr:otherNames>Diana</gtr:otherNames><gtr:surname>Peerlinck</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6703"><gtr:id>0925B96B-BC30-43D8-9914-EC54BAAD7739</gtr:id><gtr:title>Combining molecular imaging of gene expression and oncolytic adenoviruses for gene therapy against colorectal carcinoma.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6703</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>217342</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>R Iggo collaboration</gtr:description><gtr:id>63287CB5-4E8D-4144-A58D-5804B72F573A</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>mhMRcPgtFpC-1</gtr:outcomeId><gtr:partnerContribution>The viral plasmids vpKHl and pMB2O were obtained from R.Iggo, St.Andrews University,</gtr:partnerContribution><gtr:piContribution>Constitutive activation of the Wnt signalling pathway has been reported in more than 8O% of colorectal cancers and the team lead by R.Iggo has generated an adenovirus that selectively replicates in cancer cells with activated Wnt signalling pathway. As part of a collaboration with R.Iggo, we plan to insert the Na/I symporter expression cassette in the adenoviral genome by reEombinatib in yeast. All viruses genaated: will be tested extensively in vitro in different cell lines of human origin. For each virus the kinetics of replication, the virus yield and the extent of cytopathic effect will be determined. The ability of the infected cells to take up radioactive iodine will be examined. The most selective and efficient virus will be used for in vivo work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DDF67BAF-4D1E-487A-A950-AD65BC050E7D</gtr:id><gtr:title>Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f6cfc54d10c2e8e8cd5766b917cbfc"><gtr:id>f8f6cfc54d10c2e8e8cd5766b917cbfc</gtr:id><gtr:otherNames>Hingorani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>G6PBMbsKsjN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9DCD172-6977-4AB9-A9AD-95E90BF71DE9</gtr:id><gtr:title>Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca1505e725a52d53470f6132cbd54ed"><gtr:id>4ca1505e725a52d53470f6132cbd54ed</gtr:id><gtr:otherNames>Peerlinck I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>d61P4QMvkSW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>733BD27B-D61B-4FD8-BB8E-8459942F0067</gtr:id><gtr:title>Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ca1505e725a52d53470f6132cbd54ed"><gtr:id>4ca1505e725a52d53470f6132cbd54ed</gtr:id><gtr:otherNames>Peerlinck I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>B3A9FF39C7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82EC6F6A-17AE-4F6C-A3B5-BAA04C1BED88</gtr:id><gtr:title>SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a9ff59288783ab26e03c2e293d41b9b"><gtr:id>1a9ff59288783ab26e03c2e293d41b9b</gtr:id><gtr:otherNames>Merron A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>3B1327ADE0C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0747F147-1462-42F2-952A-DC0E1302FB30</gtr:id><gtr:title>Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f6cfc54d10c2e8e8cd5766b917cbfc"><gtr:id>f8f6cfc54d10c2e8e8cd5766b917cbfc</gtr:id><gtr:otherNames>Hingorani M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>gEQnSum9ZiV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1661B90-32E4-46BE-8D34-A03B3D378B9D</gtr:id><gtr:title>Cancer-specific transgene expression mediated by systemic injection of nanoparticles.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ea24ab4b5325686f2a4f772731e1c4e"><gtr:id>8ea24ab4b5325686f2a4f772731e1c4e</gtr:id><gtr:otherNames>Chisholm EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>K396gbdqVNr</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6703</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>